His primary areas of study are Internal medicine, Cardiology, Heart failure, Valsartan and Endocrinology. Internal medicine and Surgery are frequently intertwined in his study. His biological study spans a wide range of topics, including Survival rate and Placebo.
His research integrates issues of Randomized controlled trial, Randomization, ACE inhibitor and Hazard ratio in his study of Heart failure. His work carried out in the field of Valsartan brings together such families of science as Angiotensin II and Anemia. The study incorporates disciplines such as Natriuretic peptide, C-reactive protein and Confidence interval in addition to Endocrinology.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Myocardial infarction and Endocrinology. His Ejection fraction, Valsartan, Natriuretic peptide and Atrial fibrillation study in the realm of Internal medicine connects with subjects such as In patient. His work deals with themes such as Clinical trial, Surgery and Blood pressure, Diastole, which intersect with Cardiology.
His Heart failure research includes elements of Proportional hazards model, Heart disease, Intensive care medicine and Hazard ratio. His Myocardial infarction research incorporates themes from Hemodynamics, Lisinopril and ACE inhibitor. Angiotensin II and Diabetes mellitus are among the areas of Endocrinology where the researcher is concentrating his efforts.
Roberto Latini focuses on Internal medicine, Cardiology, Heart failure, Ejection fraction and Sepsis. His Internal medicine research includes themes of Gastroenterology and Diabetes mellitus. His studies deal with areas such as Body mass index and Type 2 diabetes as well as Cardiology.
Roberto Latini combines subjects such as Obesity paradox, Incidence and Bioinformatics with his study of Heart failure. His research in Ejection fraction intersects with topics in Pulmonary embolism, Ambulatory, Cause of death and Hazard ratio. He has researched Sepsis in several fields, including Oxygen transport and Albumin.
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Natriuretic peptide and Gastroenterology. His Internal medicine study incorporates themes from Diabetes mellitus and Endocrinology. The various areas that Roberto Latini examines in his Cardiology study include Resuscitation and Cardiopulmonary resuscitation.
His study in Heart failure is interdisciplinary in nature, drawing from both Body mass index, Inflammation and Clinical endpoint. In his research, N terminal pro b type natriuretic peptide is intimately related to Troponin T, which falls under the overarching field of Natriuretic peptide. As a member of one scientific family, Roberto Latini mostly works in the field of Ejection fraction, focusing on Interquartile range and, on occasion, Atrial fibrillation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients
L Gattinoni;L Brazzi;P Pelosi;R Latini.
The New England Journal of Medicine (1995)
Effect of prone positioning on the survival of patients with acute respiratory failure
Luciano G. Gattinoni;Gianni Tognoni;Antonio Pesenti;Paolo Taccone.
The New England Journal of Medicine (2001)
Comparison of candesartan, enalapril, and their combination in congestive heart failure : randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study : the RESOLVD Pilot Study Investigators
R. S. McKelvie;S. Yusuf;D. Pericak;A. Avezum.
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
Inder S. Anand;Lloyd D. Fisher;Yann Tong Chiang;Roberto Latini.
Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure
Roberto Latini;Roberto Latini;Serge Masson;Inder S. Anand;Emil Missov.
Albumin Replacement in Patients with Severe Sepsis or Septic Shock
Pietro Caironi;Gianni Tognoni;Serge Masson;Roberto Fumagalli.
The New England Journal of Medicine (2014)
Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials
M G Franzosi;E Santoro;G Zuanetti;C Baigent.
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
Michael Brines;Giovanni Grasso;Giovanni Grasso;Fabio Fiordaliso;Alessandra Sfacteria.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
Laura Calvillo;Roberto Latini;Jan Kajstura;Annarosa Leri.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis.
Sachin Sud;Jan O. Friedrich;Jan O. Friedrich;Paolo Taccone;Federico Polli.
Intensive Care Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: